Webinars
4 March, 2020 8:00 PST | 11:00 EST | 16:00 GMT CLICK HERE TO REGISTER In this 30 minute webinar, researchers and pathologists from the University of New Mexico will discuss their recently published study using the HALO...
Aiforia Webinar with Charles River Laboratories — Wednesday, ...
Learn more and register today! Source:...
Webinar | January 21st, 2020 | 11 am CET and 1 pm EST | 20 min session How do you find meaningful phenotypes in your data? Technologies like mass cytometry and multiplex fluorescence staining have changed the game when it comes to...
WEBINAR: Integrate Machine Learning and Deep Learning APPs into Mod...
- Artificial Intelligence
- Business
- Clinical Laboratories
- Clinical Pathology
- Cloud Computing
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Image Analysis
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Marketing
- New Digital Imaging Technologies
- Pathology News
- Vendor products
- Webinars
REGISTER NOW Just like a recipe, every image analysis workflow is made up of steps. By solving one problem at a time, workflows become more manageable and get you to your result quicker. During this webinar, image analysis expert Dave Mason...
REGISTER NOW How do you decipher information from complex imaging technologies? Hyperplexing technologies have drastically increased the number of biomarkers that can be analyzed in tissue sections, but finding meaningful differences...
Webinar Invitation: Nuclei Segmentation Using Artificial Intelligence
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Cloud Computing
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- File format
- Health Technology Collaboration
- Image Analysis
- Informatics
- Laboratory Informatics
- Medical Research
- Pathology News
- Vendor products
- Web/Tech
- Webinars
- Whole slide
REGISTER NOW Imagine an APP for nuclei segmentation that is reliable and can be used by anyone in your lab. Recent advances in deep learning and artificial intelligence have enabled Visiopharm to develop novel tools for nuclei...